{"organizations": [], "uuid": "7b2afd3342d56c8308304f046dc3ea49155b3ef0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180307.html", "section_title": "Archive News &amp; Video for Wednesday, 07 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-perrigo-announces-final-fda-approv/brief-perrigo-announces-final-fda-approval-and-planned-launch-for-the-store-brand-otc-equivalent-of-mucinex-dm-maximum-strength-extended-release-tablets-idUSASB0C977", "country": "US", "domain_rank": 408, "title": "BRIEF-Perrigo Announces Final FDA Approval And Planned Launch For The Store Brand OTC Equivalent Of Mucinex DM Maximum Strength Extended Release Tablets", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-03-07T22:05:00.000+02:00", "replies_count": 0, "uuid": "7b2afd3342d56c8308304f046dc3ea49155b3ef0"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-perrigo-announces-final-fda-approv/brief-perrigo-announces-final-fda-approval-and-planned-launch-for-the-store-brand-otc-equivalent-of-mucinex-dm-maximum-strength-extended-release-tablets-idUSASB0C977", "ord_in_thread": 0, "title": "BRIEF-Perrigo Announces Final FDA Approval And Planned Launch For The Store Brand OTC Equivalent Of Mucinex DM Maximum Strength Extended Release Tablets", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "neutral"}, {"name": "reuters", "sentiment": "neutral"}, {"name": "perrigo", "sentiment": "neutral"}, {"name": "perrigo company plc", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 7 (Reuters) - Perrigo Company Plc:\n* PERRIGO ANNOUNCES FINAL FDA APPROVAL AND PLANNED LAUNCH FOR THE STORE BRAND OTC EQUIVALENT OF MUCINEX® DM MAXIMUM STRENGTH EXTENDED RELEASE TABLETS\n* PERRIGO - ‍FINALIZING PLANS TO LAUNCH CO’S STORE BRAND EQUIVALENT OF MUCINEX DM MAXIMUM STRENGTH FOR 2018 COUGH-COLD SEASON​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-07T22:05:00.000+02:00", "crawled": "2018-03-08T17:38:05.029+02:00", "highlightTitle": ""}